✦ LIBER ✦

Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts

✍ Scribed by Ahmed El-Zawahry; John McKillop; Christina Voelkel-Johnson

Book ID: 119897656
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 429 KB
Volume: 5
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-5-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The topoisomerase I inhibitor topotecan

The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis

✍ Thomas S. Griffith; Troy J. Kemp 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 410 KB

Efficacy of SSG and SSG/IFNα2 against hu

Efficacy of SSG and SSG/IFNα2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action

✍ Jing Li; Daniel J. Lindner; Carol Farver; Ernest C. Borden; Taolin Yi 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 424 KB

Modulation of the Tumor Microvasculature

Modulation of the Tumor Microvasculature by Phosphoinositide-3 Kinase Inhibition Increases Doxorubicin Delivery In Vivo

✍ Qayum, N.; Im, J.; Stratford, M. R.; Bernhard, E. J.; McKenna, W. G.; Muschel, R 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 631 KB